Piracetam has been found to have very few side effects, and those it has are typically "few, mild, and transient."<ref name=sympt>{{Cite journal|pmid=9527146 |doi=10.1136/jnnp.64.3.344 |pmc=2169975 |year=1998 |last1=Koskiniemi |first1=M |last2=Van Vleymen |last3=Hakamies |last4=Lamusuo |last5=Taalas |title=Piracetam relieves symptoms in progressive myoclonus epilepsy: a multicentre, randomised, double blind, crossover study comparing the efficacy and safety of three dosages of oral piracetam with placebo |volume=64 |issue=3 |pages=344–8 |journal=Journal of neurology, neurosurgery, and psychiatry |first2=B |first3=L |first4=S |first5=J}}</ref> A large-scale, 12-week trial of high-dose piracetam found no adverse effects occurred in the group taking piracetam as compared to the [[placebo]] group.<ref>{{Cite journal|pmid=10338106 |year=1999 |last1=De Reuck |first1=J |last2=Van Vleymen |title=The clinical safety of high-dose piracetam--its use in the treatment of acute stroke |volume=32 Suppl 1 |pages=33–7 |journal=Pharmacopsychiatry |first2=B |doi=10.1055/s-2007-979234}}</ref> Many other studies have likewise found piracetam to be well tolerated.<ref name=sympt /><ref name="ReferenceC">{{Cite journal|pmid=11346373 |year=2001 |last1=Fedi |first1=M |last2=Reutens |last3=Dubeau |last4=Andermann |last5=D'agostino |last6=Andermann |title=Long-term efficacy and safety of piracetam in the treatment of progressive myoclonus epilepsy |volume=58 |issue=5 |pages=781–6 |journal=Archives of neurology |doi=10.1001/archneur.58.5.781 |first2=D |first3=F |first4=E |first5=D |first6=F}}</ref><ref>{{Cite journal|last1=Giurgea |first1=C. |last2=Salama |first2=M. |title=Nootropic drugs |journal=Prog Neuropsychopharmacol |volume=1 |year=1977 |pages=235–247 |doi=10.1016/0364-7722(77)90046-7|issue=3–4}}</ref>

 


 
Symptoms of general excitability, including [[anxiety]], [[insomnia]], [[irritability]], [[headache]], [[Psychomotor agitation|agitation]], [[Anxiety|nervousness]], [[tremor]], and [[hyperkinesia]], are occasionally reported.<ref name="compendium" /><ref name="Chouinard, G. 1983 pp.100-106">{{Cite journal|pmid=6415738 |doi=10.1007/BF00429000 |year=1983 |last1=Chouinard |first1=G |last2=Annable |last3=Ross-Chouinard |last4=Olivier |last5=Fontaine |title=Piracetam in elderly psychiatric patients with mild diffuse cerebral impairment |volume=81 |issue=2 |pages=100–6 |journal=Psychopharmacology |first2=L |first3=A |first4=M |first5=F}}</ref><ref name=pmid342247>{{Cite journal|pmid=342247 |doi=10.1159/000114922 |year=1978 |last1=Hakkarainen |first1=H |last2=Hakamies |title=Piracetam in the treatment of post-concussional syndrome. A double-blind study |volume=17 |issue=1 |pages=50–5 |journal=European neurology |first2=L}}</ref> Other reported side effects include [[somnolence]], [[weight gain]], [[clinical depression]], [[weakness]], increased [[libido]], and [[hypersexuality]].<ref name="compendium" />

 

